XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   128,138,311,000      
Beginning balance at Dec. 31, 2020 $ 146,379 $ 1,282 $ 643,269 $ 0 $ (498,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of issuance costs (in shares)   68,170,579,000      
Issuance of common stock, net of issuance costs 457,483 $ 682 456,801    
Issuance of common stock upon exercise of warrants (in shares)   1,866,758,000      
Issuance of common stock upon exercise of warrants 1,121 $ 18 1,103    
Non-cash stock-based compensation 3,300   3,300    
Issuance of common stock under stock plans, net of taxes ( in shares)   3,704,330,000      
Issuance of common stock under stock plans, net of taxes (5,497) $ 37 (5,534)    
Other comprehensive loss (296)     (296)  
Net loss (42,690)       (42,690)
Ending balance (in shares) at Sep. 30, 2021   201,879,978,000      
Ending balance at Sep. 30, 2021 559,800 $ 2,019 1,098,939 (296) (540,862)
Beginning balance (in shares) at Jun. 30, 2021   197,964,476,000      
Beginning balance at Jun. 30, 2021 576,123 $ 1,980 1,100,932 (307) (526,482)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and common stock warrants, net of issuance costs (162)   (162)    
Non-cash stock-based compensation 1,880   1,880    
Issuance of common stock under stock plans, net of taxes ( in shares)   3,915,502,000      
Issuance of common stock under stock plans, net of taxes (3,672) $ 39 (3,711)    
Other comprehensive loss 11     11  
Net loss (14,380)       (14,380)
Ending balance (in shares) at Sep. 30, 2021   201,879,978,000      
Ending balance at Sep. 30, 2021 $ 559,800 $ 2,019 1,098,939 (296) (540,862)
Beginning balance (in shares) at Dec. 31, 2021 201,988,662 201,988,662,000      
Beginning balance at Dec. 31, 2021 $ 547,255 $ 2,020 1,103,224 (614) (557,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and common stock warrants, net of issue costs (in shares)   33,333,336,000      
Issuance of common stock and common stock warrants, net of issuance costs 139,008 $ 333 138,675    
Issuance of common stock upon exercise of warrants (in shares)   4,677,000      
Issuance of common stock upon exercise of warrants 3   3    
Non-cash stock-based compensation 12,625   12,625    
Issuance of common stock under stock plans, net of taxes ( in shares)   1,895,057,000      
Issuance of common stock under stock plans, net of taxes 225 $ 19 206    
Other comprehensive loss (1,554)     (1,554)  
Net loss $ (72,620)       (72,620)
Ending balance (in shares) at Sep. 30, 2022 237,221,732 237,221,732,000      
Ending balance at Sep. 30, 2022 $ 624,942 $ 2,372 1,254,733 (2,168) (629,995)
Beginning balance (in shares) at Jun. 30, 2022   235,165,951,000      
Beginning balance at Jun. 30, 2022 663,768 $ 2,353 1,249,880 (2,256) (586,209)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Non-cash stock-based compensation 4,361   4,361    
Issuance of common stock under stock plans, net of taxes ( in shares)   2,055,781,000      
Issuance of common stock under stock plans, net of taxes 511 $ 19 492    
Other comprehensive loss 88     88  
Net loss $ (43,786)       (43,786)
Ending balance (in shares) at Sep. 30, 2022 237,221,732 237,221,732,000      
Ending balance at Sep. 30, 2022 $ 624,942 $ 2,372 $ 1,254,733 $ (2,168) $ (629,995)